OpenURL Connection Search

Select item for more details and to access through your institution.

Genetic Screens for Enhancers of brahma Reveal Functional Interactions Between the BRM Chromatin-Remodeling Complex and the Delta-Notch Signal Transduction Pathway in Drosophila.
Published in:
Genetics, 2005, v. 170, n. 4, p. 1761, doi. 10.1534/genetics.105.041327
By:
- Armstrong, Jennifer A.;
- Sperling, Adam S.;
- Deuring, Renate;
- Manning, Laurina;
- Moseley, Sarah L.;
- Papoulas, Ophelia;
- Piatek, Caroline I.;
- Doe, Chris Q.;
- Tamkun, John W.
Publication type:
Article
One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.
Published in:
European Journal of Haematology, 2021, v. 106, n. 3, p. 389, doi. 10.1111/ejh.13564
By:
- Kulasekararaj, Austin G.;
- Hill, Anita;
- Langemeijer, Saskia;
- Wells, Richard;
- González Fernández, F. Ataúlfo;
- Gaya, Anna;
- Ojeda Gutierrez, Emilio;
- Piatek, Caroline I.;
- Mitchell, Lindsay;
- Usuki, Kensuke;
- Bosi, Alberto;
- Brodsky, Robert A.;
- Ogawa, Masayo;
- Yu, Ji;
- Ortiz, Stephan;
- Röth, Alexander;
- Lee, Jong Wook;
- Peffault de Latour, Régis
Publication type:
Article
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria.
Published in:
PLoS ONE, 2020, v. 15, n. 9, p. 1, doi. 10.1371/journal.pone.0237497
By:
- Peipert, John Devin;
- Kulasekararaj, Austin G.;
- Gaya, Anna;
- Langemeijer, Saskia M. C.;
- Yount, Susan;
- Gonzalez-Fernandez, F. Ataulfo;
- Ojeda Gutierrez, Emilio;
- Martens, Christa;
- Sparling, Amy;
- Webster, Kimberly A.;
- Cella, David;
- Tomazos, Ioannis;
- Ogawa, Masayo;
- Piatek, Caroline I.;
- Wells, Richard;
- Sicre de Fontbrune, Flore;
- Röth, Alexander;
- Mitchell, Lindsay;
- Hill, Anita;
- Kaiser, Karen
Publication type:
Article
Value of routine staging imaging studies for patients with stage III breast cancer.
Published in:
Journal of Surgical Oncology, 2016, v. 114, n. 8, p. 917, doi. 10.1002/jso.24436
By:
- Piatek, Caroline I.;
- Ji, Lingyun;
- Kaur, Chandan;
- Russell, Christy A.;
- Tripathy, Debu;
- Church, Terry;
- Sposto, Richard;
- Sener, Stephen F.;
- Garcia, Agustin A.
Publication type:
Article
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.
Published in:
Acta Haematologica, 2020, v. 143, n. 3, p. 244, doi. 10.1159/000501538
By:
- Piatek, Caroline I.;
- Bocian, Hillel;
- Algaze, Sandra;
- Weitz, Ilene C.;
- O'Connell, Casey;
- Liebman, Howard A.
Publication type:
Article
Autoimmune Myelofibrosis: Clinical Features, Course, and Outcome.
Published in:
Acta Haematologica, 2017, v. 138, n. 3, p. 129, doi. 10.1159/000479103
By:
- Piatek, Caroline I.;
- Vergara-Lluri, Maria E.;
- Pullarkat, Vinod;
- Siddiqi, Imran N.;
- O'Connell, Casey;
- Brynes, Russell K.;
- Feinstein, Donald I.
Publication type:
Article

Found: 6

Genetic Screens for Enhancers of brahma Reveal Functional Interactions Between the BRM Chromatin-Remodeling Complex and the Delta-Notch Signal Transduction Pathway in Drosophila.

One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.

Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria.

Value of routine staging imaging studies for patients with stage III breast cancer.

A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.

Autoimmune Myelofibrosis: Clinical Features, Course, and Outcome.